7 Results for "

fluconazole resistance

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "fluconazole resistance" in MCE Product Catalog:

Cat. No.: HY-N10402
CAS No.: 1187954-93-3
Category:  

Alkaloids Microorganisms

Target:  

Fungal Bacterial Parasite

Norbatzelladine L (Compound 2) is an inhibitor of the catalytic and functional activity of Pdr5p transporter. Norbatzelladine L inhibits Pdr5p ATPase activity with an IC50 of 3.8 µM. Norbatzelladine L shows antifungal, antiparasitic, antiviral, antibacterial and antitumoral activities .
loading...
    loading...
Cat. No.: HY-162271
Target:  

Topoisomerase Fungal

Research Areas:  

Infection

Antibacterial agent 187 (IKE7) is a derivative containing imidazole and triazolacridone structures that target yeast topoisomerase II. Antibacterial agent 187 has antifungal activity and MIC value of resistance to fluconazole (HY-B0101) is 32-64 μg/mL .
loading...
    loading...
Cat. No.: HY-155198
CAS No.: 3032485-62-1
Target:  

Fungal

Research Areas:  

Infection

Antifungal agent 72 (Compound B8) is a potent antifungal agent. Antifungal agent 72 suppresses the function of efflux pump and down-regulates the resistance-associated genes through blocking the Pdr1-KIX interaction (Ki: 11.7 μM). Antifungal agent 72 is active against Fluconazole (HY-B0101)-resistant with a MIC value of 63 ng/mL, and shows synergistic inhibitory activity with Fluconazole. Antifungal agent 72 can be used for C. glabrata infection research .
loading...
    loading...
Cat. No.: HY-116686
CAS No.: 897776-15-7
Target:  

Cytochrome P450 Fungal

Research Areas:  

Infection

Inz-1 is a potent and selective mitochondrial cytochrome bc1 inhibitor for yeast (IC50=8.092 μM) over humans (IC50=45.320 μM). Inz-1 reverses Fluconazole (HY-B0101) or other triazole antifungals’ resistance in the pathogenic fungus Candida albicans .
loading...
    loading...
Cat. No.: HY-181404
Target:  

Fungal P-glycoprotein

Research Areas:  

Infection

PA36-2 is an Mdr1 inhibitor and azole resistance reversal agent, with a IC50 of 1.0 μg/mL and a Kd of 4.209 μM against Candida albicans Mdr1. By effectively inhibiting the activity of the Mdr1 efflux pump, PA36-2 prevents the pumping of substrates out of cells, enhances the intracellular accumulation of azole antibiotics, and exerts a synergistic effect with antifungal agents such as Fluconazole (FLC) (HY-B0101). PA36-2 can be used in the research of azole-resistant candidiasis .
loading...
    loading...
Cat. No.: HY-184314
CAS No.: 3122934-62-4
Target:  

Fungal

Research Areas:  

Infection

Antifungal agent-166 is an antifungal agent. The combination of Antifungal agent-166 and Fluconazole exerts synergistic bacteriostatic effects against fluconazole-resistant Candida albicans. Antifungal agent-166 exhibits bacteriostatic activity against both Candida glabrata and Cryptococcus neoformans. Antifungal agent-166 reverses the fluconazole resistance of strains by downregulating ergosterol synthesis-related genes, drug resistance-related genes and virulence-related genes. Antifungal agent-166 can enhance the efficacy of Fluconazole in Galleria mellonella and mouse candidiasis models, reduce fungal load and improve survival rate. Antifungal agent-166 can be used in the research of fungal infections .
loading...
    loading...
Cat. No.: HY-187652
CAS No.: 2883514-82-5
Synonyms: CMLD012336
Target:  

Fungal

Research Areas:  

Infection

Azoffluxin (CMLD012336) is a Cdr1 inhibitor. Azoffluxin enhances the activity of Fluconazole (HY-B0101) and other intracellular-acting antifungal agents against drug-resistant Candida. Azoffluxin is used for research on fungal efflux-mediated azole resistance and combined antifungal therapy .
loading...
    loading...